#United States #Novato, California #National Eczema Association #Eczema #PRMRP

Eczema Receives New Funding Opportunity for Research

In a promising development for those affected by eczema, the National Eczema Association (NEA) has reported a significant victory. Eczema has been re-listed as an eligible condition for funding through the Department of Defense's Peer-Reviewed Medical Research Program (PRMRP) for the fiscal year 2025. This re-inclusion represents an important step forward in research and treatment options for the 31 million Americans who live with this chronic skin condition.

The decision to allow this funding was made by Congress, demonstrating a commitment to advancing medical research for eczema, something that has been lacking since the condition was last included in fiscal year 2023. This initiative comes as a result of relentless advocacy by NEA Ambassadors and grassroots supporters, who have tirelessly campaigned for the recognition and funding necessary to tackle this prevalent disorder.

Kristin Belleson, the CEO of NEA, emphasized that this achievement is credited to the unwavering efforts of NEA Ambassadors who have engaged with Congressional representatives at events like NEA’s annual Virtual Hill Day. She noted, "This accomplishment would not have been possible without the tireless advocacy of NEA Ambassadors and grassroots advocates."

Ambassadors like Jiwon Park, who lives with eczema, are ecstatic about the decision. Park conveyed her excitement, saying, “I am thrilled to see eczema once again included in the PRMRP. It’s clear that research is essential; it’s the key to unlocking better treatments and a brighter future for patients living with eczema.” Her confidence reflects the broader sentiment in the eczema community that scientific inquiry can lead to necessary advancements in care and treatment options.

The funding from the PRMRP is expected to facilitate groundbreaking research that could lead to new treatments and vital discoveries in the understanding of eczema. The focus is not only on improving existing treatments but also on advancing the scientific comprehension of this condition. By investing in innovative research, the program aims to enhance care for millions of affected individuals, including service members in the armed forces who may also suffer from eczema. However, there are concerns as recent funding cuts threaten the program's sustainability. NEA affiliates are urging Congress to restore the funding back to its previous level of $370 million to ensure that eczema remains a priority in fiscal year 2026 and beyond.

This funding victory comes at an exciting time for the NEA and the eczema community as a whole, which is witnessing a surge in scientific interest and the development of new treatments. Founded in 1988, the National Eczema Association stands as the largest nonprofit organization dedicated to serving those who live with eczema and their caregivers. NEA focuses on enhancing the understanding of eczema, advocating for patient needs, and advancing research. With its strategic plan, Blueprint 2025, NEA is committed to driving towards a future where eczema is no longer a burden.

The NEA continues to uplift the voices of those affected by eczema, providing resources and programs designed to improve the quality of life for patients and their families. As awareness grows, it is hoped that significant advances in research will lead to more effective treatments and a better understanding of this condition, ultimately culminating in a world where eczema can be effectively managed or perhaps even eliminated.

For more information, visit NationalEczema.org.